| CAS ID: | 53-03-2 |
| Molecular Formula: | C21H26O5 |
| Molecular Weight: | 358.4 g/mol |
| Monoisotopic Mass: | 358.178 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | LODOTRA | PREDNISONE | DELTA-DOME | PREDNISONE INTENSOL | PREDNICEN-M | ORASONE | PARACORT | Sterapred | SERVISONE | RAYOS | LIQUID PRED | DELTASONE | FERNISONE | DECORTISYL | METICORTEN | CORTAN | CORTANCYL |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1 | See All |
| InChI Key: | XOFYZVNMUHMLCC-ZPOLXVRWSA-N | |
| Smiles: | C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00440349 | Disease | Retroperitoneal fibrosis |
| Phase | Phase 2 | Status | Unknown |
| First Received | February 27, 2007 | Last Verified | February 27, 2007 |
| Sponsor | University of Parma | ||
Trial Record 2
| ClinicalTrial ID | NCT03070522 | Disease | Cystic fibrosis |
| Phase | Phase 3 | Status | Recruiting |
| First Received | March 3, 2017 | Last Verified | April 17, 2018 |
| Sponsor | The Hospital for Sick Children | ||
Trial Record 3
| ClinicalTrial ID | NCT00518310 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Not Applicable | Status | Unknown |
| First Received | August 20, 2007 | Last Verified | August 20, 2007 |
| Sponsor | Thorax National Institute | ||
Trial Record 4
| ClinicalTrial ID | NCT00262405 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | December 6, 2005 | Last Verified | December 3, 2015 |
| Sponsor | University of Michigan | ||
Trial Record 5
| ClinicalTrial ID | NCT01240850 | Disease | Retroperitoneal fibrosis |
| Phase | Phase 3 | Status | Unknown |
| First Received | November 15, 2010 | Last Verified | November 15, 2010 |
| Sponsor | University of Parma | ||
Trial Record 6
| ClinicalTrial ID | NCT00650091 | Disease | Pulmonary fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | April 1, 2008 | Last Verified | June 2, 2015 |
| Sponsor | Duke University | ||
Trial Record 7
| ClinicalTrial ID | NCT01570764 | Disease | Systemic sclerosis |
| Phase | Phase 3 | Status | Active, not recruiting |
| First Received | April 4, 2012 | Last Verified | March 19, 2018 |
| Sponsor | Assistance Publique - Hôpitaux de Paris | ||
Trial Record 8
| ClinicalTrial ID | NCT01570764 | Disease | Pulmonary fibrosis |
| Phase | Phase 3 | Status | Active, not recruiting |
| First Received | April 4, 2012 | Last Verified | March 19, 2018 |
| Sponsor | Assistance Publique - Hôpitaux de Paris | ||
Trial Record 9
| ClinicalTrial ID | NCT00006054 | Disease | Fibrosis |
| Phase | Not Applicable | Status | Terminated |
| First Received | July 6, 2000 | Last Verified | October 15, 2009 |
| Sponsor | Fairview University Medical Center | ||
Trial Record 10
| ClinicalTrial ID | NCT02703194 | Disease | Retroperitoneal fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | March 9, 2016 | Last Verified | March 6, 2019 |
| Sponsor | Chinese PLA General Hospital | ||
Trial Record 11
| ClinicalTrial ID | NCT01987791 | Disease | Liver fibrosis |
| Phase | Status | Unknown | |
| First Received | November 19, 2013 | Last Verified | November 19, 2013 |
| Sponsor | Peking University People's Hospital | ||